Aurinia Pharmaceuticals, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CA05156V1022
USD
15.31
-0.6 (-3.77%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
70.01
62.47
59.87
67.77
57.19
50.30
45.09
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
70.01
62.47
59.87
67.77
57.19
50.30
45.09
Raw Material Cost
7.12
8.57
5.55
6.04
8.91
7.75
5.39
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
16.59
10.04
26.90
26.58
27.28
30.52
37.25
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
1.12
1.07
1.15
1.21
1.20
1.28
1.31
Selling and Distribution Expenses
26.02
20.34
37.03
42.37
44.93
47.70
50.07
Other Expenses
-1.03
-0.54
-1.99
-2.47
-2.44
-2.63
-2.83
Total Expenditure (Excl Depreciation)
40.57
34.66
50.69
51.45
57.92
61.00
65.69
Operating Profit (PBDIT) excl Other Income
29.4
27.799999999999997
9.200000000000001
16.299999999999997
-0.7000000000000001
-10.700000000000001
-20.6
Other Income
-6.06
-0.86
8.49
-0.31
4.48
8.65
-4.51
Operating Profit (PBDIT)
28.25
31.81
22.53
20.91
8.59
2.80
-20.16
Interest
1.12
1.07
1.15
1.21
1.20
1.28
1.31
Exceptional Items
-0.11
-1.53
-15.35
0.00
-1.07
-6.68
0.00
Gross Profit (PBDT)
62.89
53.89
54.32
61.74
48.28
42.55
39.70
Depreciation
4.86
4.86
4.86
4.89
4.84
4.85
4.95
Profit Before Tax
22.16
24.35
1.17
14.81
1.48
-10.01
-26.42
Tax
0.64
1.01
-0.26
0.46
0.76
0.74
0.46
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
21.51
23.34
1.43
14.35
0.72
-10.75
-26.88
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
21.51
23.34
1.43
14.35
0.72
-10.75
-26.88
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
21.51
23.34
1.43
14.35
0.72
-10.75
-26.88
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
335.30
350.19
377.48
388.00
364.62
359.48
377.95
Earnings per share (EPS)
0.16
0.16
0.01
0.1
0.01
-0.07
-0.19
Diluted Earnings per share
0.16
0.16
0.01
0.1
0.01
-0.07
-0.19
Operating Profit Margin (Excl OI)
42.06%
44.52%
15.33%
24.08%
-1.28%
-21.26%
-45.68%
Gross Profit Margin
38.6%
46.75%
10.08%
29.07%
11.05%
-10.26%
-47.6%
PAT Margin
30.73%
37.37%
2.39%
21.17%
1.26%
-21.37%
-59.6%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jun 2025 is 12.00% vs 4.34% in Mar 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2025 is -7.73% vs 1,564.29% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2025 is 4.89% vs 133.57% in Mar 2025

stock-summary

Interest

QoQ Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025

Compare Quarterly Results Of Aurinia Pharmaceuticals, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
70.01
59.95
10.06
16.78%
Other Operating Income
0.00
0.00
0.00
Total Operating income
70.01
59.95
10.06
16.78%
Raw Material Cost
7.12
62.90
-55.78
-88.68%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
16.59
0.00
16.59
Power Cost
0
0
0.00
Manufacturing Expenses
1.12
0.00
1.12
Selling and Distribution Expenses
26.02
31.46
-5.44
-17.29%
Other Expenses
-1.03
7.94
-8.97
-112.97%
Total Expenditure (Excl Depreciation)
40.57
173.73
-133.16
-76.65%
Operating Profit (PBDIT) excl Other Income
29.44
-113.77
143.21
125.88%
Other Income
-6.06
4.10
-10.16
-247.80%
Operating Profit (PBDIT)
28.25
-97.73
125.98
128.91%
Interest
1.12
0.00
1.12
Exceptional Items
-0.11
0.00
-0.11
Gross Profit (PBDT)
62.89
-2.95
65.84
2,231.86%
Depreciation
4.86
11.94
-7.08
-59.30%
Profit Before Tax
22.16
-109.67
131.83
120.21%
Tax
0.64
1.99
-1.35
-67.84%
Provisions and contingencies
0
0
0.00
Profit After Tax
21.51
-111.66
133.17
119.26%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
21.51
-111.66
133.17
119.26%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
21.51
-111.66
133.17
119.26%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
335.30
698.49
-363.19
-52.00%
Earnings per share (EPS)
0.16
-0.33
0.49
148.48%
Diluted Earnings per share
0.16
-0.33
0.49
148.48%
Operating Profit Margin (Excl OI)
42.06%
-189.78%
0.00
231.84%
Gross Profit Margin
38.60%
-163.02%
0.00
201.62%
PAT Margin
30.73%
-186.25%
0.00
216.98%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 7.00 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 12.00% vs 4.34% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 22.38% vs 37.83% in Jun 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 2.15 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -7.73% vs 1,564.29% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 2,971.43% vs 106.09% in Jun 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 3.43 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 4.89% vs 133.57% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 736.59% vs 121.47% in Jun 2024

Quarterly - Interest
Interest 0.11 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -8.33% vs 1,100.00% in Jun 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 42.06%
in Jun 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 has improved from Jun 2024